Market Capitalization (Millions $) |
217 |
Shares
Outstanding (Millions) |
40 |
Employees |
1,230 |
Revenues (TTM) (Millions $) |
328 |
Net Income (TTM) (Millions $) |
-14 |
Cash Flow (TTM) (Millions $) |
31 |
Capital Exp. (TTM) (Millions $) |
6 |
Angiodynamics Inc
AngioDynamics Inc is a leading provider of innovative medical technologies and devices for minimally-invasive surgical procedures that are used in hospitals, clinics, and physician offices worldwide. The company's product portfolio includes medical devices that are designed to diagnose, treat, and manage a wide range of medical conditions, including peripheral vascular disease, cancer, and other serious medical conditions.
AngioDynamics was founded in Queensbury, New York, in 1988, and has since grown to become a global medical technology company. The company operates in more than 60 countries and employs over 1,400 people worldwide. The company's headquarters is located in Latham, New York.
The product portfolio of AngioDynamics includes a variety of medical devices and technologies that are used in interventional procedures including:
1. Peripheral Vascular Interventions: AngioDynamics offers a variety of products to diagnose and treat peripheral artery disease. These include the market-leading VenaCure EVLT laser system for treatment of varicose vein and the AngioVac cannula and circuit for extraction of clot in various vascular procedures.
2. Oncology: AngioDynamics provides a variety of technologies to diagnose and treat cancer, including the NanoKnife Irreversible Electroporation System, which uses electrical pulses to kill cancer cells.
3. Interventional Radiology: AngioDynamics' interventional radiology products include the BioFlo PICC, which is designed to reduce complications associated with central venous catheterization and the Bioflo Port, a power-injected, long-term use catheter.
4. Surgical Oncology: AngioDynamics offers a variety of products for surgical oncology, including radiofrequency ablation (RFA), microwave ablation, and cryoablation systems for the treatment of solid tumors.
In addition to its product portfolio, AngioDynamics also has a strong focus on research and development. The company invests a significant amount of resources in the development of new technologies and devices for minimally-invasive surgical procedures.
AngioDynamics has a strong reputation for quality and innovation, and its products are used by medical professionals across the globe. With its broad portfolio of medical technologies, AngioDynamics is well-positioned to continue growing and advancing the field of minimally-invasive surgical procedures.
Company Address: 14 Plaza Drive Latham 12110 NY
Company Phone Number: 795-1400 Stock Exchange / Ticker: NASDAQ ANGO
ANGO is expected to report next financial results on March 30, 2024. |
|
|